Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
General Internal Medicine
•
Hematology
•
Pediatric Hematology
•
Cardiology
•
Preventive Cardiology
Which classes of medications are reasonable to consider in cases of acute pericarditis in a patient with G6PD deficiency?
Related Questions
In patients with lupus nephritis, and MAHA with positive anti-phospholipid autoantibodies, what are the considerations to use or not use anti-coagulation therapy?
How would you approach secondary stroke prevention in an adult with Hemoglobin SC disease?
Can lupus anticoagulant be positive despite a normal aPTT?
How would you approach post-operative VTE prophylaxis for renal transplant in patients with a prior history of provoked VTE?
How is your experience with point-of-care INR systems for home monitoring of vitamin K antagonists?
How do you manage significant asymptomatic indirect hyperbilirubinemia in patients with hemolytic diseases (SCD, HS, etc.)?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
How do you manage arthritis resulting from deferiprone in transfusion dependent thalassemia?
How do you approach the work-up for a patient with iron deficiency anemia who is not responding to oral iron therapy?
How would you approach the risk-benefit ratio of systemic anticoagulation in certain clinical scenarios such as atrial fibrillation or LV thrombus when a patient's history is also notable for type B aortic dissection or other aortic pathology such as aortic ulceration?
